The Board of Director of Tivoli A/S has adopted the Interim Report for the period 1 January – 31 March…
Garching / Munich, Germany and VANCOUVER, British Columbia, April 24, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading…
For immediate release iSTAR Medical’s MINIject® demonstrates significant sustained 5-year efficacy in treating glaucoma in STAR-GLOBAL trial Five-year safety profile…
London, UK – 24th April 2025. Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on…
Quadient Named a Leader in the SPARK Matrix™: Customer Communication Management Report for 2025 QKS Group recognizes Quadient for its…
MYT Netherlands Parent B.V. (“Mytheresa”) and Richemont announce the successful completion of Mytheresa’s acquisition of YOOX NET-A-PORTER (“YNAP”) 24 April 2025…
Primary endpoint met, no drug-related serious adverse events Positive hematoma and edema volume evolutionRecruitment stopped early due to positive exploratory…
Tarkett Participation increases the price offered in its public buy-out OfferTarkett's Supervisory Board issues a favorable reasoned opinion based on…
PRESS RELEASE Paris, April 24, 2025, 8:00 am Eramet: 2.7bn€ in economic contribution and 260,000 beneficiaries of social initiatives in the…
Leiden, the Netherlands, April 24, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited)…
This website uses cookies.